FB 04 - Universitätsmedizin
Johannes Gutenberg-Universität Mainz
- 06131/17-9704 oder 9799 (Sekretariat)
- 06131/17-9669
Stratmann, Jan Alexander; Acker, Fabian; Aspacher, Lukas et al.
Additional chemotherapy for EGFRm patients with the continued presence of plasma ctDNA EGFRm at week 3 after start of osimertinib first-line treatment (PACE).JOURNAL OF CLINICAL ONCOLOGY. Bd. 40. H. 16. 2022
Loke, Justin; Labopin, Myriam; Craddock, Charles et al.
Additional cytogenetic features determines outcome in patients allografted for TP53 mutant acute myeloid leukemiaCANCER. 2022
Kuntic, Marin; Djordjevic, Ivana; Oelze, Matthias et al.
Additive Effects of Environmental Noise and PM Pollution on the Cardio-Pulmonary SystemFREE RADICAL BIOLOGY AND MEDICINE. Bd. 180. 2022 S. 74-74
Bruce, Iain A.; Ezgu, Fatih S.; Kampmann, Christoph et al.
Addressing the need for patient-friendly medical communications: adaptation of the 2019 recommendations for the management of MPS VI and MPS IVAORPHANET JOURNAL OF RARE DISEASES. Bd. 17. H. 1. 2022
Laessig, Anne Katrin
Adenotonsillectomy may improve Phonation in Children CommentLARYNGO-RHINO-OTOLOGIE. Bd. 101. H. 04. 2022 S. 278-+
Mayer, Arnulf; Wenzel, Witali; Wollschlaeger, Daniel et al.
Adjuvant chemoradiotherapy in elderly patients with head and neck cancer: a monoinstitutional, two-to-one pair-matching analysisSTRAHLENTHERAPIE UND ONKOLOGIE. Bd. 198. H. 2. 2022 S. 159-170
Mallmann, P.; Vordermark, D.; Feyer, P. et al.
Adjuvant therapy of endometrial cancerGYNAKOLOGIE. Bd. 55. H. 7. 2022 S. 501-508
Lindenberg, Katajun; Mueller, Kai
Adolescents and emerging adults suffering from Internet use disordersJOURNAL OF BEHAVIORAL ADDICTIONS. Bd. 11. 2022 S. 49-49
Lazarus, ?; Mark, Henry E.; Anstee, Quentin M. et al.
Advancing the global public health agenda for NAFLD: a consensus statementNATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY. Bd. 19. H. 1. 2022 S. 60-78
Thein, Anna-sophie; Hedengran, Anne; Azuara-blanco, Augusto et al.
Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus StatementAMERICAN JOURNAL OF OPHTHALMOLOGY. Bd. 241. 2022 S. 190-197